ARCHIVES

ACS Board allocated $37.5 Million to Research; More Coming

This article is from The Cancer Letter archive.

Vol. 13 No. 08 | February 20, 1987

Download PDF Visit The Full Archive

Related Articles

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

NIH Seeks Comment On Reorg Plan For Oncology Study Sections

April 5, 2002

Postponed Surgery For Low-Grade Prostate Cancer Adds No Risk

April 29, 2011

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980